Supriya Lifescience Ltd Share Price (SUPRIYA)
as on
| Source : NSE
Supriya Lifescience Ltd Stock Performance
as on August 19, 2025 at 4:01 PM IST
Day's Low
Day's High
₹650₹680.45
4.02%
Downside
0.47%
Upside
52 Week's Low
52 Week's High
₹495.65₹84226.81%
Downside
24.33%
Upside
| Market Stats | |
| Previous Close | ₹661.05 |
| Open | ₹661.50 |
| Volume | 1.49L |
| Upper Circuit | ₹793.25 |
| Lower Circuit | ₹528.85 |
| Day's Low | ₹650 |
| Day's High | ₹680.45 |
| 52 Week Low | ₹495.65 |
| 52 Week High | ₹842 |
| Returns % | |
| 1 Month Return | -5.31 % |
| 3 Month Return | -5.78 % |
| 1 Year Return | + 23.73 % |
| 3 Year Return | + 80.05 % |
| 5 Year Return | + 69.13 % |
Supriya Lifescience Ltd Stock Fundamentals & Key Indicators
Check Supriya Lifescience Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹5,320.32 Cr
Return on Equity (ROE)
15.73
PE Ratio (TTM)
0Return on capital employed (ROCE)
22.05
Beta (LTM)
1.87
P/B Ratio
3.27
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-22.07
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Supriya Lifescience Ltd Stock's Interest Amongst Investors
Supriya Lifescience Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Supriya Lifescience Ltd.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Supriya Lifescience Ltd. Average target price of ₹843
Source: S&P Global Market Intelligence
Supriya Lifescience Ltd Share Price Target
Get share price movements and forecasts by analysts on Supriya Lifescience Ltd.
Supriya Lifescience Ltd price forecast by 1 analysts
Upside of27.52%
High
₹843
Target
₹843.00
Low
₹843
Supriya Lifescience Ltd target price ₹843, a slight upside of 27.52% compared to current price of ₹677.25. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Supriya Lifescience Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Supriya Lifescience Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Supriya Lifescience Ltd Financial Results
Get the annual and quarterly financial summary of Supriya Lifescience Ltd, including revenue, profit, loss and more.
Supriya Lifescience Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Supriya Lifescience Ltd.
Supriya Lifescience Ltd Earnings Results
Supriya Lifescience Ltd’s net profit fell -22.07% since last year same period to ₹34.79Cr in the Q1 2025-2026. On a quarterly growth basis, Supriya Lifescience Ltd has generated -30.94% fall in its net profits since last 3-months.
Read More about Earnings ResultsSupriya Lifescience Ltd Dividends May,2024
In the quarter ending March 2024, Supriya Lifescience Ltd has declared dividend of ₹0.80 per share on 28 May 2024 - translating a dividend yield of 0.12%.
Read More about Dividends
Indices Featuring Supriya Lifescience Ltd Stock
Check stock indices that include Supriya Lifescience Ltd.
Supriya Lifescience Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Supriya Lifescience Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.3% | 0.00 | |
| Foreign Institutions | 6.78% | ||
| Mutual Funds | 0.68% | 3.49 | |
| Retail Investors | 20.06% | ||
| Others | 4.18% | 16.08 |
Supriya Lifescience Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Supriya Lifescience Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 5,320.32 | 13.83% | 0.00 | 119 | 570 | |
| NA | 738.47 | 32.13% | 0.51 | 421 | 1,280 | |
| NA | 20.25 | 6.48% | 0.00 | NA | 58 | |
| NA | 88.03 | -2.89% | 0.00 | 3 | 53 | |
| BUY | 26,821.04 | 66.05% | 0.51 | 659 | 3,917 |
Supriya Lifescience Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Supriya Lifescience Ltd.
Supriya Lifescience Maintains BUY Rating with Target Price - 03 Jun, 2025
Supriya Lifescience reported a 16.4% YoY revenue increase, with EBITDA and PAT exceeding estimates. Analysts revised EPS estimates upward, maintaining a BUY rating with a target price of INR 843.Supriya Lifescience Projects Strong Revenue Growth - 28 May, 2025
Supriya Lifescience anticipates over 20% annual revenue growth, driven by new product launches and a strong operational performance. Q4FY25 revenue rose 16.4%, with profit after tax up 36.4%. The company expects margins to stabilize between 33% and 35%. A new 10-year API supply contract is projected to add ₹60-70 crore annually at peak. The focus remains on expanding its anaesthetic and specialty therapies portfolio.
Insights on Supriya Lifescience Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 0.66% to 0.68% in Jun 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, SUPRIYA stock has moved up by 23.7%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 32.0% return, outperforming this stock by 8.3%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.7% return, outperforming this stock by 56.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.30% of holdings in Jun 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 20.26% to 20.06% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 7.19% to 6.78% in Jun 2025 quarter
About Supriya Lifescience Ltd
Revenue: ₹145.07Cr as on June 2025 (Q1 FY26)
Net Profit: ₹34.79Cr as on June 2025 (Q1 FY26)
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
| Organisation | Supriya Lifescience Ltd |
| Industry | Pharmaceuticals |
| CEO | Satish Waman Wagh |
| E-voting on shares | Click here to vote |
Mutual Funds that own Supriya Lifescience Ltd Stock
Check out the Mutual Funds with significant holdings in Supriya Lifescience Ltd.
FAQs
What is Supriya Lifescience Ltd share price today?
Supriya Lifescience Ltd share price today stands at ₹677.25, Open: ₹661.5, Previous Close: ₹661.05, High: ₹680.45, Low: ₹650, 52 Week High: ₹842, 52 Week Low: ₹495.65 as on .
How to buy Supriya Lifescience Ltd shares ?
To buy Supriya Lifescience Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for SUPRIYA or Supriya Lifescience Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Supriya Lifescience Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Supriya Lifescience Ltd?
Today's traded volume of Supriya Lifescience Ltd is 1.49L. Which means that 1.49L shares of Supriya Lifescience Ltd were bought and sold on the stock market during today's trading session.
What is Supriya Lifescience Ltd's market cap today?
Today's market capitalisation of Supriya Lifescience Ltd is ₹5,320.32 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Supriya Lifescience Ltd?
Supriya Lifescience Ltd’s 52 week high is ₹842 and 52 week low is ₹495.65. The current share price of Supriya Lifescience Ltd is ₹677.25, which is -19.57% down from its 52 week high and 36.64% up from its 52 week low.